We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.575 | 0.55 | 0.60 | 0.60 | 0.55 | 0.60 | 4,839,664 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 390k | -385k | -0.0002 | -27.50 | 12.2M |
TIDMPXS
RNS Number : 1765M
Provexis PLC
12 September 2019
12 September 2019
Provexis plc
("Provexis" or the "Company")
Director / PDMR notification
Provexis, the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow(R) heart-health functional food ingredient, announces that Ian Ford, CEO and CFO, purchased a total of 5,000,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") on 12 September 2019 at an average price of 0.338 pence per Ordinary Share.
Following this purchase, Mr Ford has a total beneficial interest in 10,000,000 Ordinary Shares, equivalent to 0.50% of the Company's issued share capital.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Ian Ford (Director and PDMR) - shares acquired on behalf of Mr Ford's children (under the age of 18) who are persons closely associated with Mr Ford -------------------------- ----------------------------------------------- 2 Reason for the notification --------------------------------------------------------------------------- a) Position/status See 1a) above -------------------------- ----------------------------------------------- b) Initial notification Initial notification / Amendment -------------------------- ----------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --------------------------------------------------------------------------- a) Name PROVEXIS PLC -------------------------- ----------------------------------------------- b) LEI 21380042E3Y3N9VZ6N48 -------------------------- ----------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --------------------------------------------------------------------------- a) Description of the Ordinary Shares of 0.1p each financial instrument, type of instrument Identification code ISIN: GB00B0923P27 -------------------------- ----------------------------------------------- b) Nature of the transaction Purchase of ordinary shares -------------------------- ----------------------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) 0.33 pence 2,500,000 and 0.345 pence 2,500,000 ----------- -------------------------- ----------------------------------------------- d) Aggregated information - Aggregated volume - Price 5,000,000 shares Average price of 0.338 pence per share -------------------------- ----------------------------------------------- e) Date of the transaction 12 September 2019 -------------------------- ----------------------------------------------- f) Place of the transaction London Stock Exchange, AIM Market -------------------------- -----------------------------------------------
For further information please contact:
Provexis plc Tel: 07490 391888 Dawson Buck, Chairman enquiries@provexis.com Ian Ford, CEO & CFO Allenby Capital Limited Tel: 020 3328 5656 Nick Naylor / Liz Kirchner
Notes for editors
About Provexis plc
AIM-listed Provexis is focused on the development, licensing and sales of its proprietary, scientifically-proven Fruitflow(R) heart-health functional food ingredient.
Provexis was founded in 1999 and is headquartered in Reading, Berkshire.
Provexis shares are traded on the AIM market of the London Stock Exchange under the ticker symbol PXS.
For further information, please visit www.provexis.com and www.fruitflowplus.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGGUQGBUPBGCP
(END) Dow Jones Newswires
September 12, 2019 10:19 ET (14:19 GMT)
1 Year Provexis Chart |
1 Month Provexis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions